EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Next Science's enterprise value is A$64.81 Mil.
Next Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$33.10 Mil. Therefore, Next Science's EV-to-Revenue for today is 1.96.
The historical rank and industry rank for Next Science's EV-to-Revenue or its related term are showing as below:
ASX:NXS'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.46 Med: 14.08 Max: 76.32
Current: 1.96
During the past 6 years, the highest EV-to-Revenue of Next Science was 76.32. The lowest was 1.46. And the median was 14.08.
ASX:NXS's EV-to-Revenue is ranked better than 56.37% of 1020
companies
in the Drug Manufacturers industry
Industry Median: 2.255
vs ASX:NXS: 1.96
As of today (2024-06-08), Next Science's stock price is A$0.265.
Next Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.14. Therefore, Next Science's PS Ratio for today is 1.88.
Next Science EV-to-Revenue Historical Data
The historical data trend for Next Science's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Next Science's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Next Science's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Next Science's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Next Science's EV-to-Revenue falls into.
Next Science's current Enterprise Value is A$64.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Next Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$33.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Next Science's share price for today is A$0.265.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Next Science EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Next Science's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:NXS has been successfully added to your 